Evolent Health, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2014 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Evolent Health, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2014 to Q2 2024.
  • Evolent Health, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 115M shares, a 3.06% increase year-over-year.
  • Evolent Health, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 111M shares, a 18.7% increase from 2022.
  • Evolent Health, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 93.7M shares, a 8.87% increase from 2021.
  • Evolent Health, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 86.1M shares, a 1.34% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 115M +3.41M +3.06% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 114M +6.36M +5.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 111M +17.6M +18.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-23
Q3 2023 112M +13M +13.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 111M +21.2M +23.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 108M +18.3M +20.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 93.7M +7.63M +8.87% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-23
Q3 2022 99.3M +13.5M +15.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 90.1M +4.62M +5.41% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 89.5M +4.84M +5.72% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 86.1M +1.14M +1.34% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-23
Q3 2021 85.8M +628K +0.74% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 85.4M +99K +0.12% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 84.7M -123K -0.15% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 84.9M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-24
Q3 2020 85.2M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 85.3M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 84.8M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q3 2018 78M +7.67M +10.9% Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-08
Q2 2018 77.2M +17.7M +29.8% Apr 1, 2018 Jun 30, 2018 10-Q 2018-08-09
Q1 2018 75.4M +22.8M +43.3% Jan 1, 2018 Mar 31, 2018 10-Q 2018-05-10
Q4 2017 64.4M +19.3M +42.9% Oct 1, 2017 Dec 31, 2017 10-K 2018-03-01
Q3 2017 70.3M +27.2M +63.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 59.5M +16.9M +39.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 52.6M +10.4M +24.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 45M -1.11M -2.4% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-01
Q3 2016 43.1M +1.64M +3.96% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 42.6M +5.95M +16.2% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 42.2M +39.2M +1312% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 46.1M Oct 1, 2015 Dec 31, 2015 10-K 2018-03-01
Q3 2015 41.5M +39M +1555% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 36.6M +34.4M +1513% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 2.99M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q3 2014 2.51M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 2.27M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.